drugset / Trial / NCT00887718
Positron Emission Tomography(PET) in Lymphoma Assessment
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
This study examines the role of a diagnostic test called Positron Emission Tomography (PET) scanning in patients with malignant lymphoma. The primary goal of this study is to find out how well PET scanning can detect malignant (cancerous) lymphoma, and how often this extra information will result in a change of stage of disease, or will result in a change in treatment management plans of patients with lymphoma.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | 18F-FDG | Diagnostic / imaging agent | — | — |